Phase II trial of carboplatin and etopos
โ
John Crown; Thomas Hakes; Bonnie Reichman; David Lebwohl; Theresa Gilewski; Anto
๐
Article
๐
1993
๐
John Wiley and Sons
๐
English
โ 345 KB
๐ 1 views
## Background: High-dose chemotherapy with hematopoietic support produces high rates of response in metastatic breast cancer. to facilitate new high-dose regimens there is a need to identify active agents with toxicity limited to hematopoietic suppression. cisplatin/etoposide is a highly active reg